La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Unimicron Technology Croissance future
Future contrôle des critères 5/6
Unimicron Technology devrait augmenter ses bénéfices et son chiffre d'affaires de 47% et de 19.2% par an respectivement. Le BPA devrait croître de de 42.9% par an. Le rendement des capitaux propres devrait être 20.1% dans 3 ans.
Informations clés
46.8%
Taux de croissance des bénéfices
42.7%
Taux de croissance du BPA
Electronic croissance des bénéfices | 23.1% |
Taux de croissance des recettes | 19.0% |
Rendement futur des capitaux propres | 20.1% |
Couverture par les analystes | Good |
Dernière mise à jour | 24 Sep 2024 |
Mises à jour récentes de la croissance future
Analysts Are Updating Their Unimicron Technology Corp. (TWSE:3037) Estimates After Its Second-Quarter Results
Aug 03Earnings Beat: Unimicron Technology Corp. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Apr 25Unimicron Technology Corp. (TWSE:3037) Released Earnings Last Week And Analysts Lifted Their Price Target To NT$220
Feb 29Recent updates
At NT$149, Is It Time To Put Unimicron Technology Corp. (TWSE:3037) On Your Watch List?
Sep 29Does Unimicron Technology (TWSE:3037) Have A Healthy Balance Sheet?
Sep 12The Price Is Right For Unimicron Technology Corp. (TWSE:3037) Even After Diving 26%
Aug 17Analysts Are Updating Their Unimicron Technology Corp. (TWSE:3037) Estimates After Its Second-Quarter Results
Aug 03We Like These Underlying Return On Capital Trends At Unimicron Technology (TWSE:3037)
Jul 30Unimicron Technology's (TWSE:3037) Dividend Is Being Reduced To NT$3
Jun 20Unimicron Technology Corp.'s (TWSE:3037) Popularity With Investors Is Clear
Jun 12Earnings Beat: Unimicron Technology Corp. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Apr 25Why Unimicron Technology Corp. (TWSE:3037) Could Be Worth Watching
Apr 18Unimicron Technology (TWSE:3037) Seems To Use Debt Quite Sensibly
Apr 05Unimicron Technology Corp. (TWSE:3037) Released Earnings Last Week And Analysts Lifted Their Price Target To NT$220
Feb 29Unimicron Technology (TPE:3037) Seems To Use Debt Quite Sensibly
Apr 19Here's Why We Think Unimicron Technology (TPE:3037) Is Well Worth Watching
Apr 07Unimicron Technology (TPE:3037) Has Rewarded Shareholders With An Exceptional 494% Total Return On Their Investment
Mar 05Is There Now An Opportunity In Unimicron Technology Corp. (TPE:3037)?
Feb 20Is Unimicron Technology Corp. (TPE:3037) A Smart Choice For Dividend Investors?
Feb 09Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
12/31/2026 | 167,648 | 25,442 | 26,952 | 45,983 | 8 |
12/31/2025 | 149,754 | 21,793 | 19,063 | 37,358 | 15 |
12/31/2024 | 118,550 | 9,439 | 1,745 | 24,100 | 15 |
6/30/2024 | 106,515 | 9,525 | -6,000 | 19,501 | N/A |
3/31/2024 | 103,873 | 10,318 | -4,872 | 19,506 | N/A |
12/31/2023 | 104,036 | 11,980 | 7,618 | 30,900 | N/A |
9/30/2023 | 115,036 | 16,433 | 13,092 | 38,285 | N/A |
6/30/2023 | 125,944 | 22,406 | 27,812 | 53,675 | N/A |
3/31/2023 | 136,344 | 28,047 | 30,129 | 60,828 | N/A |
12/31/2022 | 140,489 | 29,619 | 28,619 | 61,082 | N/A |
9/30/2022 | 134,364 | 27,255 | 40,047 | 71,317 | N/A |
6/30/2022 | 125,055 | 22,908 | 33,993 | 63,774 | N/A |
3/31/2022 | 113,451 | 16,705 | 27,941 | 53,786 | N/A |
12/31/2021 | 104,563 | 13,222 | 19,302 | 42,957 | N/A |
9/30/2021 | 96,575 | 10,275 | 5,292 | 26,934 | N/A |
6/30/2021 | 91,469 | 7,656 | -1,306 | 18,265 | N/A |
3/31/2021 | 89,149 | 7,263 | 1,355 | 18,321 | N/A |
12/31/2020 | 87,893 | 5,462 | 3,360 | 18,164 | N/A |
9/30/2020 | 87,889 | 4,493 | -1,267 | 11,315 | N/A |
6/30/2020 | 87,799 | 4,159 | -296 | 11,840 | N/A |
3/31/2020 | 85,830 | 3,257 | 1,076 | 12,600 | N/A |
12/31/2019 | 82,536 | 3,260 | -1,090 | 10,277 | N/A |
9/30/2019 | 80,443 | 2,933 | 3,062 | 13,607 | N/A |
6/30/2019 | 78,881 | 2,653 | 4,947 | 14,479 | N/A |
3/31/2019 | 76,444 | 1,917 | 2,220 | 11,253 | N/A |
12/31/2018 | 75,733 | 1,705 | 4,565 | 13,535 | N/A |
9/30/2018 | 74,116 | 1,769 | 717 | 11,283 | N/A |
6/30/2018 | 69,674 | 465 | -4,227 | 7,365 | N/A |
3/31/2018 | 66,893 | 486 | N/A | 8,061 | N/A |
12/31/2017 | 64,993 | 414 | N/A | 5,698 | N/A |
9/30/2017 | 62,584 | 325 | N/A | 6,306 | N/A |
6/30/2017 | 61,502 | 347 | N/A | 7,724 | N/A |
3/31/2017 | 61,971 | 331 | N/A | 8,022 | N/A |
12/31/2016 | 62,638 | 12 | N/A | 8,925 | N/A |
9/30/2016 | 63,771 | 187 | N/A | 9,742 | N/A |
6/30/2016 | 65,304 | 645 | N/A | 10,301 | N/A |
3/31/2016 | 66,555 | 627 | N/A | 10,031 | N/A |
12/31/2015 | 64,650 | 288 | N/A | 10,243 | N/A |
9/30/2015 | 63,693 | -881 | N/A | 8,177 | N/A |
6/30/2015 | 62,778 | -615 | N/A | 7,293 | N/A |
3/31/2015 | 61,623 | -147 | N/A | 7,344 | N/A |
12/31/2014 | 61,755 | 497 | N/A | 6,623 | N/A |
9/30/2014 | 59,509 | 579 | N/A | 7,028 | N/A |
6/30/2014 | 58,754 | 562 | N/A | 6,864 | N/A |
3/31/2014 | 58,873 | 642 | N/A | 7,682 | N/A |
12/31/2013 | 59,935 | 1,173 | N/A | 9,002 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de 3037 ( 47% par an) est supérieure au taux d'épargne ( 1% ).
Bénéfices vs marché: Les bénéfices de 3037 ( 47% par an) devraient croître plus rapidement que le marché TW ( 18.8% par an).
Croissance élevée des bénéfices: Les bénéfices de 3037 devraient augmenter de manière significative au cours des 3 prochaines années.
Chiffre d'affaires vs marché: Le chiffre d'affaires de 3037 ( 19.2% par an) devrait croître plus rapidement que le marché TW ( 11.8% par an).
Croissance élevée des revenus: Le chiffre d'affaires de 3037 ( 19.2% par an) devrait croître plus lentement que 20% par an.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Le retour sur capitaux propres de 3037 devrait être élevé dans 3 ans ( 20.1 %)